BPC-157

Muscle/RecoveryHealing / RegenerativeExperimental

Synthetic gastric pentadecapeptide widely sold as a research chemical for tissue-repair models. Not FDA-approved; FDA has flagged it for compounding risk. WADA prohibits BPC-157 under S0.

Calculate Dose

For research use only.

Key Facts

CAS: 137525-51-0
Molecular Weight (MW): 1419.5 g/mol
Half-life: ~30 minutes to 4 hours
Unit: mcg
Administration Route: Subcutaneous
Frequency: 1–3x daily
Last updated: 8/23/2026
Targets: VEGFR2 / FAK pathwaysNitric oxide systemGI mucosa

Overview

Synthetic gastric pentadecapeptide widely sold as a research chemical for tissue-repair models. Not FDA-approved; FDA has flagged it for compounding risk. WADA prohibits BPC-157 under S0.

Protocol

Dosage Range: 250–500 mcg per dose
Frequency: 1–3x daily
Cycle: 4–8 weeks on, 4 weeks off
Administration Route: Subcutaneous
Reconstitution Guide: 3 mL BAC water for 5 mg vial

Science

Mechanism of Action

Preclinical work reports angiogenesis, nitric-oxide modulation, and growth-factor (VEGFR2, FAK) signaling that may support tendon, muscle, and gut mucosal healing in animals. Robust randomized human efficacy data are lacking.